Skip to main content

Advertisement

Log in

LeFort colpocleisis for recurrent pelvic organ prolapse

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

The causes of recurrence of pelvic organ prolapse (POP) are sufficiently understood. However, few studies are available evaluating reoperation for recurrence of POP. This study evaluates the efficacy and safety of LeFort colpocleisis for recurrent POP.

Methods

We reviewed data from patients with recurrent POP who underwent LerFort colpocleisis at a center between March 2012 and April 2017. Quality of life was assessed using the Pelvic Floor Distress Inventory Questionnaire (PFDI-20) scores. The Patient Global Impression of Improvement scale (PGI-I) was used to assess self-perceived success and subjective measures of satisfaction. The Clavien-Dindo classification (CD) was used to assess the safety of the procedure. Chi-square and paired t-tests were used to compare the same patients before and after treatment in the follow-up.

Results

Twenty-six patients with recurrent POP after previous prolapse surgery underwent LeFort colpocleisis. Most of these patients had at least one comorbidity. The mean age (years) was 71.8 (7.3). The mean time to recurrent POP was 5.602 (3.643) years. There were no intraoperative bladder lesions or rectal lesions. At mean follow-up of 33.1 months, all patients had no recurrence (< stage 2), significant resolution of awareness of prolapse (P < 0.05), and significantly improved satisfaction on PGI-I after surgery. Minor complications were classified as CD II level in four cases (15.4%).

Conclusion

This study suggests that LeFort colpocleisis is feasible and safe for recurrent POP, especially in older women with comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wilkins MF, Wu JM. Lifetime risk of surgery for stress urinary incontinence or pelvic organ prolapse. Minerva Ginecol. 2017;69(2):171–7.

    PubMed  Google Scholar 

  2. Dallas KB, Rogo-Gupta L, Elliott CS. What impacts the all cause risk of reoperation after pelvic organ prolapse repair? A comparison of mesh and native tissue approaches in 110,329 women. J Urol. 2018;3(18):42415–9.

    Google Scholar 

  3. Jonsson Funk M, Visco AG, Weidner AC, Pate V, Wu JM. Long-term outcomes of vaginal mesh versus native tissue repair for anterior vaginal wall prolapse. Int Urogynecol J. 2013;24(8):1279–85.

    Article  Google Scholar 

  4. Manodoro S, Frigerio M, Cola A, Spelzini F, Milani R. Risk factors for recurrence after hysterectomy plus native-tissue repair as primary treatment for genital prolapse. Int Urogynecol J. 2017;29(4):1–7.

    Google Scholar 

  5. Lavelle ES, Giugale LE, Winger DG, Li W, CarterBrooks CM, Shepherd JP. Prolapse recurrence following sacrocolpopexy vs uterosacral ligament suspension: a comparison stratified by pelvic organ prolapse quantification stage. American Journal of Obstetrics & Gynecology. 2018.

  6. Haylen BT, Freeman RM, Lee J, Swift SE, Cosson M, Deprest J, et al. International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related to native tissue female pelvic floor surgery. Neurourol Urodyn. 2012;31(4):406–14. https://doi.org/10.1002/nau.22199.

    Article  PubMed  Google Scholar 

  7. Abbasy S, Kenton K. Obliterative procedures for pelvic organ prolapse. Clin Obstet Gynecol. 2010;53(1):86–98.

    Article  Google Scholar 

  8. Guerette NL, Bena JF, Davila GW. Transobturator slings for stress incontinence: using urodynamic parameters to predict outcomes. Int Urogynecol J. 2008;19(1):97–102.

    Article  CAS  Google Scholar 

  9. Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstetr Gynecol. 2005;193(1):103.

    Article  CAS  Google Scholar 

  10. Srikrishna S, Robinson D, Cardozo L. Validation of the patient global impression of improvement (PGI-I) for urogenital prolapse. Int Urogynecol J. 2010;21(5):523–8.

    Article  Google Scholar 

  11. Mothes AR, Mothes HK, Radosa MP, Runnebaum IB. Systematic assessment of surgical complications in 438 cases of vaginal native tissue repair for pelvic organ prolapse adopting Clavien-Dindo classification. Arch Gynecol Obstetr. 2014;291(6):1–5.

    Google Scholar 

  12. Mettu JR, Colaco M, Badlani GH. Evidence-based outcomes for mesh-based surgery for pelvic organ prolapse. Curr Opin Urol. 2014;24(4):370–4.

    Article  Google Scholar 

  13. Dallas KB, Rogo-Gupta L, Elliott CS. What impacts the all cause risk of reoperation after pelvic organ prolapse repair? A comparison of mesh and native tissue approaches in 110,329 women. J Urol. 2018.

  14. Wang X, Chen Y, Hua K. Pelvic symptoms, body image, and regret after LeFort colpocleisis: a long-term follow-up. J Minim Invasive Gynecol. 2017;24(3):415–9.

    Article  Google Scholar 

  15. Ismail S, Duckett J, Rizk D, Sorinola O, Kammererdoak D, Contrerasortiz O, et al. Recurrent pelvic organ prolapse: International Urogynecological Association Research and Development Committee opinion. Int Urogynecol J. 2016;27(11):1–14.

    Article  Google Scholar 

  16. Haya N, Maher M, Ballard EJIUJ. Surgical management of recurrent upper vaginal prolapse following sacral colpopexy. 2015; 26 (8):1243–1245.

  17. Mearini L, Nunzi E, Di Biase M, Costantini E. Laparoscopic management of vaginal vault prolapse recurring after pelvic organ prolapse surgery. Urol Int. 2016;97(2):158–64. https://doi.org/10.1159/000443337.

    Article  PubMed  Google Scholar 

  18. Iglesia CB, Hale DS, Lucente VR. Laparoscopic sacrocolpopexy versus transvaginal mesh for recurrent pelvic organ prolapse. Int Urogynecol J. 2013;24(3):363–70. https://doi.org/10.1007/s00192-012-1918-5.

    Article  PubMed  Google Scholar 

  19. Mikos T, Chatzipanteli M, Grimbizis GF, Tarlatzis BC. Enlightening the mechanisms of POP recurrence after LeFort colpocleisis. Case report and review. Int Urogynecol J. 2017;28(7):971–8. https://doi.org/10.1007/s00192-016-3236-9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The study was supported by grants from the Science and Technology Commission of Shanghai Municipality (no.16411963700) and General Program from Shanghai Municipal Commission of Health and Family Planning (no. 201540155).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yisong Chen or Keqin Hua.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Hu, C., Chen, Y. et al. LeFort colpocleisis for recurrent pelvic organ prolapse. Int Urogynecol J 31, 381–384 (2020). https://doi.org/10.1007/s00192-019-03969-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-019-03969-y

Keywords

Navigation